S&P 500   3,674.14 (+0.14%)
DOW   30,045.67 (+0.54%)
QQQ   304.28 (+0.14%)
AAPL   122.85 (-0.19%)
MSFT   214.46 (-0.42%)
FB   282.10 (-1.89%)
GOOGL   1,820.08 (-0.27%)
AMZN   3,187.94 (-0.49%)
TSLA   596.85 (+4.93%)
NVDA   536.01 (-1.07%)
BABA   267.05 (+2.19%)
CGC   28.87 (+2.45%)
GE   10.62 (+1.82%)
MU   70.50 (+2.01%)
AMD   92.40 (-1.43%)
T   29.18 (+0.31%)
NIO   46.64 (-2.79%)
F   9.24 (+0.43%)
ACB   11.02 (+0.64%)
NFLX   497.78 (-1.11%)
BA   239.40 (+6.95%)
GILD   60.61 (-0.85%)
DIS   153.06 (-0.36%)
S&P 500   3,674.14 (+0.14%)
DOW   30,045.67 (+0.54%)
QQQ   304.28 (+0.14%)
AAPL   122.85 (-0.19%)
MSFT   214.46 (-0.42%)
FB   282.10 (-1.89%)
GOOGL   1,820.08 (-0.27%)
AMZN   3,187.94 (-0.49%)
TSLA   596.85 (+4.93%)
NVDA   536.01 (-1.07%)
BABA   267.05 (+2.19%)
CGC   28.87 (+2.45%)
GE   10.62 (+1.82%)
MU   70.50 (+2.01%)
AMD   92.40 (-1.43%)
T   29.18 (+0.31%)
NIO   46.64 (-2.79%)
F   9.24 (+0.43%)
ACB   11.02 (+0.64%)
NFLX   497.78 (-1.11%)
BA   239.40 (+6.95%)
GILD   60.61 (-0.85%)
DIS   153.06 (-0.36%)
S&P 500   3,674.14 (+0.14%)
DOW   30,045.67 (+0.54%)
QQQ   304.28 (+0.14%)
AAPL   122.85 (-0.19%)
MSFT   214.46 (-0.42%)
FB   282.10 (-1.89%)
GOOGL   1,820.08 (-0.27%)
AMZN   3,187.94 (-0.49%)
TSLA   596.85 (+4.93%)
NVDA   536.01 (-1.07%)
BABA   267.05 (+2.19%)
CGC   28.87 (+2.45%)
GE   10.62 (+1.82%)
MU   70.50 (+2.01%)
AMD   92.40 (-1.43%)
T   29.18 (+0.31%)
NIO   46.64 (-2.79%)
F   9.24 (+0.43%)
ACB   11.02 (+0.64%)
NFLX   497.78 (-1.11%)
BA   239.40 (+6.95%)
GILD   60.61 (-0.85%)
DIS   153.06 (-0.36%)
S&P 500   3,674.14 (+0.14%)
DOW   30,045.67 (+0.54%)
QQQ   304.28 (+0.14%)
AAPL   122.85 (-0.19%)
MSFT   214.46 (-0.42%)
FB   282.10 (-1.89%)
GOOGL   1,820.08 (-0.27%)
AMZN   3,187.94 (-0.49%)
TSLA   596.85 (+4.93%)
NVDA   536.01 (-1.07%)
BABA   267.05 (+2.19%)
CGC   28.87 (+2.45%)
GE   10.62 (+1.82%)
MU   70.50 (+2.01%)
AMD   92.40 (-1.43%)
T   29.18 (+0.31%)
NIO   46.64 (-2.79%)
F   9.24 (+0.43%)
ACB   11.02 (+0.64%)
NFLX   497.78 (-1.11%)
BA   239.40 (+6.95%)
GILD   60.61 (-0.85%)
DIS   153.06 (-0.36%)
Log in
CVE:COV

Covalon Technologies Ltd. (COV.V) Stock Forecast, Price & News

C$1.13
-0.07 (-5.83 %)
(As of 12/3/2020 01:31 PM ET)
Add
Compare
Today's Range
C$1.13
Now: C$1.13
C$1.20
50-Day Range
C$1.01
MA: C$1.13
C$1.31
52-Week Range
C$0.70
Now: C$1.13
C$2.10
Volume2,500 shs
Average Volume12,805 shs
Market CapitalizationC$29.18 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has three platform technologies, including collagen matrix platform that is used to manufacture a family of products that treat chronic and infected wounds, such as diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform, which is used in a family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. It sells wound care dressing, surgical and peri-operative, and infection management products under the Covalon brand name. The company also offers development contracts, licensing agreements, and distribution contracts services. It provides its technologies, products, and services to various health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-5688400
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$26.46 million
Cash FlowC$0.15 per share
Book ValueC$0.45 per share

Profitability

Miscellaneous

Market CapC$29.18 million
Next Earnings Date1/26/2021 (Estimated)
OptionableNot Optionable
C$1.13
-0.07 (-5.83 %)
(As of 12/3/2020 01:31 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive COV News and Ratings via Email

Sign-up to receive the latest news and ratings for COV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Covalon Technologies Ltd. (COV.V) (CVE:COV) Frequently Asked Questions

How has Covalon Technologies Ltd. (COV.V)'s stock been impacted by Coronavirus (COVID-19)?

Covalon Technologies Ltd. (COV.V)'s stock was trading at C$1.58 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, COV stock has decreased by 28.5% and is now trading at C$1.13.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Covalon Technologies Ltd. (COV.V)?

Wall Street analysts have given Covalon Technologies Ltd. (COV.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Covalon Technologies Ltd. (COV.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Covalon Technologies Ltd. (COV.V)'s next earnings date?

Covalon Technologies Ltd. (COV.V) is scheduled to release its next quarterly earnings announcement on Tuesday, January 26th 2021.
View our earnings forecast for Covalon Technologies Ltd. (COV.V)
.

Who are some of Covalon Technologies Ltd. (COV.V)'s key competitors?

What other stocks do shareholders of Covalon Technologies Ltd. (COV.V) own?

Who are Covalon Technologies Ltd. (COV.V)'s key executives?

Covalon Technologies Ltd. (COV.V)'s management team includes the following people:
  • Mr. Brian E. Pedlar, Pres, CEO & Director
  • Mr. Danny Brannagan, Chief Financial Officer
  • Simon Smith, Chief Exec. Officer of Covalon Technologies Europe
  • Gerry Arambula, Pres of Covalon Technologies AG Ltd.
  • Dr. Valerio DiTizio, Co-Founder, Chief Scientific Officer & VP (Age 52)
  • Ms. Kim Crooks, VP of Operations
  • Ms. Alyssa Hrycyshyn, VP of Marketing
  • Mr. Greg Leszczynski, VP of HR
  • Mr. Hamed Abbasian, VP of Bus. Devel.

What is Covalon Technologies Ltd. (COV.V)'s stock symbol?

Covalon Technologies Ltd. (COV.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "COV."

How do I buy shares of Covalon Technologies Ltd. (COV.V)?

Shares of COV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Covalon Technologies Ltd. (COV.V)'s stock price today?

One share of COV stock can currently be purchased for approximately C$1.13.

How big of a company is Covalon Technologies Ltd. (COV.V)?

Covalon Technologies Ltd. (COV.V) has a market capitalization of C$29.18 million and generates C$26.46 million in revenue each year.

What is Covalon Technologies Ltd. (COV.V)'s official website?

The official website for Covalon Technologies Ltd. (COV.V) is www.covalon.com.

How can I contact Covalon Technologies Ltd. (COV.V)?

Covalon Technologies Ltd. (COV.V)'s mailing address is 1660 Tech Ave Unit 5, MISSISSAUGA, ON L4W 5S7, Canada. The company can be reached via phone at +1-905-5688400.

This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.